Utah Medical Products Inc. Reports Leadership Changes
Ticker: UTMD · Form: 8-K · Filed: Nov 5, 2024 · CIK: 706698
| Field | Detail |
|---|---|
| Company | Utah Medical Products Inc (UTMD) |
| Form Type | 8-K |
| Filed Date | Nov 5, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $64.09, $7,350 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, corporate-governance, financial-reporting
Related Tickers: UTMD
TL;DR
UTMD board shakeup and exec changes filed. Watch for new strategy.
AI Summary
Utah Medical Products, Inc. filed an 8-K on November 1, 2024, reporting changes in its board of directors and executive officers, along with updates on compensatory arrangements. The filing also includes financial statements and exhibits, indicating potential shifts in company leadership and financial reporting.
Why It Matters
Changes in a company's board and executive team can signal strategic shifts or governance adjustments that may impact future performance and investor confidence.
Risk Assessment
Risk Level: medium — Leadership changes and the filing of financial statements can introduce uncertainty regarding the company's future direction and performance.
Key Numbers
- 001-12575 — SEC File Number (Identifies the company's filing history with the SEC.)
- 87-0342734 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- UTAH MEDICAL PRODUCTS, INC. (company) — Registrant
- November 1, 2024 (date) — Date of Report
- Midvale, Utah (location) — Principal Executive Offices
FAQ
What specific changes occurred regarding the board of directors or certain officers?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers', but the specific details of these changes are not provided in the excerpt.
What is the significance of the 'Other Events' section in this filing?
The 'Other Events' section typically covers significant developments not otherwise covered by other 8-K items, but the specific events are not detailed in the provided text.
What types of financial statements and exhibits are included?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific content of these documents is not detailed in the excerpt.
When was the report filed and as of what date?
The report was filed on November 5, 2024, and the date of the earliest event reported is November 1, 2024.
What is Utah Medical Products, Inc.'s Standard Industrial Classification?
The company's Standard Industrial Classification is 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]'.
Filing Stats: 675 words · 3 min read · ~2 pages · Grade level 10.1 · Accepted 2024-11-05 14:42:52
Key Financial Figures
- $64.09 — 0,000 options with an exercise price of $64.09 per share that will vest over a four-ye
- $7,350 — e the UTMD standard Board Member fee of $7,350 per quarter, which will be pro-rated fo
Filing Documents
- utmd-20241101.htm (8-K) — 25KB
- utmd_ex99z1.htm (EX-99.1) — 3KB
- 0001096906-24-002072.txt ( ) — 155KB
- utmd-20241101_def.xml (EX-101.DEF) — 2KB
- utmd-20241101_lab.xml (EX-101.LAB) — 20KB
- utmd-20241101_pre.xml (EX-101.PRE) — 13KB
- utmd-20241101.xsd (EX-101.SCH) — 2KB
- utmd-20241101_htm.xml (XML) — 2KB
01—OTHER EVENTS
ITEM 8.01—OTHER EVENTS On November 5, 2024, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend. A dividend of $.305 per share is payable on January 3, 2025 to shareholders of record at the close of business on December 16, 2024. A copy of the press release is attached hereto as Exhibit 99.1.
01—FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01—FINANCIAL STATEMENTS AND EXHIBITS The following is filed as an exhibit to this report: Exhibit Number* Title of Document Location Item 99.1 Utah Medical Products, Inc. Appoints New Director and Increases Quarterly Cash Dividend This filing _______________________________________ * All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. UTAH MEDICAL PRODUCTS, INC. Dated: November 5, 2024 By: /s/ Kevin L. Cornwell Kevin L. Cornwell, Chief Executive Officer